The knockout and transgenic studies provide convincing proof that individual chemokine-chemokine receptor signalling pathways are important in atherosclerosis, particularly the CCL2/CCR2 [8, 17], CCL5/CCR5 [23] and CX3CL1/CX3CR1 [24] pathways. This evidence concerns the gene CCR2 and atherosclerosis.